Favorite this paper
How to cite this paper?
Abstract

Neuroinflammatory processes influence most neurological disorders, including Alzheimer disease and Parkinon´s disease. During their progression, microglia becomes neurotoxic through the production of nitric oxide (NO) and proinflammatory cytokines. Currently, pharmacological treatments fail to halt the progression of brain disorders and immunoactive treatments has been seen as promising. Conjugated linoleic acid (CLA) is a mixture of geometric and positional isomers of linoleic acid. Animal and human studies with CLA-rich diets have shown CLA as potent anti-inflammatory candidate. However, there are few reports on the CLA effect in central nervous system. This study investigated the anti-neuroinflammatory and neuroprotective effects of CLA in microglial cells activated by LPS (1 µg/mL). Cell viability was evaluated by MTT reduction, flow cytometry and live/dead assays. The NO secretion was measured by HPLC and Griess diazotization methods. Cytokines quantifications were determined using sandwich ELISA kits. Arginase activity was measured by spectrophotometric method. CLA (60 µM) reduced production of proinflammatory cytokine IL-1β, and at 100 µM increased the secretion of immunosuppressive cytokines IL-4 and IL-10. CLA had no effect to the levels of NO in BV2 cell-line. However, CLA at 100 µM reduced NO release (up to 26.72%) in n9 cell-line. For primary microglia, effects of NO reduction by CLA were more dramatic, with levels reduced (up to 53.65%) similar to control levels in all CLA concentrations tested. Treatments with CLA showed significant correlation between arginase activity and NO levels both for BV2 (r= -0.820; p=0.008) as for n9 (r= -0.717; p=0.037). This indicates that CLA primes microglia to drive into a M2 phenotype (neuroprotection). Consistently, co-treatment with CLA and LPS completely prevented neuronal death induced by the endotoxin: CLA increased neuron viability from 53.31% (LPS- induced neuron death) to 100.91%. Altogether, these results suggest that CLA has potential as anti-inflammatory and neuroprotective agents against microglia-mediated neuroinflammatory disorders.

Institutions
  • 1 Laboratório de Análises Avançadas em Bioquímica e Biologia Molecular / Instituto de Química / Universidade Federal do Rio de Janeiro
  • 2 Laboratório de Bioquímica de Tripanosomatídeos / Instituto Oswaldo Cruz / Fundação Oswaldo Cruz
  • 3 Laboratório de Biologia das Células Gliais / Instituto de Ciências Biomédicas / Universidade Federal do Rio de Janeiro
  • 4 Laboratório de Comunicação Celular / Instituto Oswaldo Cruz / Fundação Oswaldo Cruz
  • 5 Laboratório de Imunologia Clínica / Instituto Oswaldo Cruz / Fundação Oswaldo Cruz
  • 6 Laboratório de Biologia Estrutural / Instituto Oswaldo Cruz / Fundação Oswaldo Cruz
  • 7 Laboratório de Agregação de Proteínas e Amiloidoses / Instituto de Bioquímica Médica / Universidade Federal do Rio de Janeiro
  • 8 Laboratório de Imunoparasitologia / Instituto Oswaldo Cruz / Fundação Oswaldo Cruz
Track
  • 4. Food and Health (AS)
Keywords
conjugated linoleic acid
bioactive compound
Neurological disorders